[Brainlife] Newsletter, Vol.4 Suppl.7, 29 May 2005

top

BRAINLIFE NEWSLETTER

Volume 4, Supplement 7 - 29 May 2005	Volume 4 Archive

Low Grade Gliomas (5)

Treatment
Radiotherapy
	Karim AB, Maat B, Hatlevoll R, Menten J, Rutten EH, Thomas DG, Mascarenhas F, Horiot JC, Parvinen LM, van Reijn M, Jager JJ, Fabrini MG, van Alphen AM, Hamers HP, Gaspar L, Noordman E, Pierart M, van Glabbeke M A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844 Int J Radiat Oncol Biol Phys. 1996 Oct 1;36(3):549-56. (Clinical Study, Abstract)
	Kiebert GM, Curran D, Aaronson NK, Bolla M, Menten J, Rutten EH, Nordman E, Silvestre ME, Pierart M, Karim AB Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised phase III trial on dose response (EORTC trial 22844). EORTC Radiotherapy Co-operative Group Eur J Cancer. 1998 Nov;34(12):1902-9. (Clinical Study, Abstract)
	Martin Klein, Jan J. Heimans The Measurement of Cognitive Functioning in Low-Grade Glioma Patients After Radiotherapy Journal of Clinical Oncology, Vol 22, No 5 (March 1), 2004: pp. 966-967. (Correspondence, Reference+)
	Klein M, Heimans JJ, Aaronson NK, van der Ploeg HM, Grit J, Muller M, Postma TJ, Mooij JJ, Boerman RH, Beute GN, Ossenkoppele GJ, van Imhoff GW, Dekker AW, Jolles J, Slotman BJ, Struikmans H, Taphoorn MJ Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study Lancet. 2002 Nov 2;360(9343):1361-8. (Clinical Study, Abstract)
	Christina A. Meyers, Jeffrey S. Wefel The Use of the Mini-Mental State Examination to Assess Cognitive Functioning in Cancer Trials: No Ifs, Ands, Buts, or Sensitivity J Clin Oncol, Vol 21, Issue 19 (Oct.), 2003: 3557-3558. Originally pub. as JCO Early Release on Aug. 11 2003. (Editorial, Reference+)
	Monje ML, Palmer T Radiation injury and neurogenesis Curr Opin Neurol. 2003 Apr;16(2):129-34. (Review Article, Abstract)
	Francesco Pignatti, Martin van den Bent, Desmond Curran, Channa Debruyne, Richard Sylvester, Patrick Therasse, Denes Áfra, Philippe Cornu, Michel Bolla, Charles Vecht, Abul B.M.F. Karim for the European Organization for Research and Treatment of Cancer Brain Tumor Cooperative Group and Radiotherapy Cooperative Group Prognostic Factors for Survival in Adult Patients With Cerebral Low-Grade Glioma Journal of Clinical Oncology, Vol 20, Issue 8 (April), 2002: 2076-2084. (Clinical Study, Abstract+)
	Postma TJ, Klein M, Verstappen CC, Bromberg JE, Swennen M, Langendijk JA, Taphoorn MJ, Scheltens P, Slotman BJ, van der Ploeg HM, Aaronson NK, Heimans JJ Radiotherapy-induced cerebral abnormalities in patients with low-grade glioma Neurology. 2002 Jul 9;59(1):121-3.(Clinical Study, Abstract+)
	Koh-ichi Sakata, Masato Hareyama, Takashi Komae, Hiroki Shirato, Osamu Watanabe, Jiroh Watarai, Kenji Takai, Shogo Yamada, Emiko Tsuchida and Kunio Sakai Supratentorial Astrocytomas and Oligodendrogliomas Treated in the MRI Era Japanese Journal of Clinical Oncology, June 2001, 31:240-245. (Clinical Study, Abstract & PDF Full Text)
	Swennen MH, Bromberg JE, Witkamp TD, Terhaard CH, Postma TJ, Taphoorn MJ Delayed radiation toxicity after focal or whole brain radiotherapy for low-grade glioma J Neurooncol. 2004 Feb;66(3):333-9. (Clinical Study, Abstract+)
	Taphoorn MJ Neurocognitive sequelae in the treatment of low-grade gliomas Semin Oncol. 2003 Dec;30(6 Suppl 19):45-8.(Review Article, Abstract)
Chemotherapy
	M. Brada, L. Viviers, C. Abson, F. Hines, J. Britton, S. Ashley, S. Sardell, D. Traish, A. Gonsalves, P. Wilkins and C. Westbury Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas Annals of Oncology 14:1715-1721, December 2003. (Clinical Study, Abstract & PDF Full Text)
	Paul Brown, Jan Buckner Temozolomide: Too Early for Definitive Conclusions Journal of Clinical Oncology, Vol 21, Issue 19 (October 1), 2003: 3710. (Correspondence, Reference+)
	Buckner JC, Gesme D Jr, O'Fallon JR, Hammack JE, Stafford S, Brown PD, Hawkins R, Scheithauer BW, Erickson BJ, Levitt R, Shaw EG, Jenkins R Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities J Clin Oncol 2003 Jan 15;21(2):251-5 (Clinical Study, Abstract & PDF Full Text)
	K. Hoang-Xuan, L. Capelle, M. Kujas, S. Taillibert, H. Duffau, J. Lejeune, M. Polivka, E. Crinière, Y. Marie, K. Mokhtari, A.F. Carpentier, F. Laigle, J.M. Simon, P. Cornu, P. Broët, M. Sanson, J.Y. Delattre Temozolomide As Initial Treatment for Adults With Low-Grade Oligodendrogliomas or Oligoastrocytomas and Correlation With Chromosome 1p Deletions Journal of Clinical Oncology, Vol 22, No 15 (August 1), 2004: pp. 3133-3138. (Clinical Study)
	Sridharan Gururangan, Christina M. Cavazos, David Ashley, James E. Herndon, II, Carol S. Bruggers, Albert Moghrabi, Deborah L. Scarcella, Melody Watral, Sandra Tourt-Uhlig, David Reardon, Henry S. Friedman Phase II Study of Carboplatin in Children With Progressive Low-Grade Gliomas Journal of Clinical Oncology, Vol 20, Issue 13 (July), 2002: 2951-2958. (Clinical Study, Abstract+)
	Lafay-Cousin L, Holm S, Qaddoumi I, Nicolin G, Bartels U, Tabori U, Huang A, Bouffet E Weekly vinblastine in pediatric low-grade glioma patients with carboplatin allergic reaction Cancer. 2005 Apr 28; [Epub ahead of print] (Clinical Study)
	A. Pace, A. Vidiri, E. Galiè, M. Carosi, S. Telera, A. M. Cianciulli, P. Canalini, D. Giannarelli, B. Jandolo and C. M. Carapella Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response Annals of Oncology 14:1722-1726, December 2003. (Clinical Study, Abstract)
	Jennifer A. Quinn, David A. Reardon, Allan H. Friedman, Jeremy N. Rich, John H. Sampson, James M. Provenzale, Roger E. McLendon, Sridharan Gururangan, Darell D. Bigner, James E. Herndon, II, Nicholas Avgeropoulos, Jonathan Finlay, Sandra Tourt-Uhlig, Mary Lou Affronti, Brandon Evans, Valerie Stafford-Fox, Sara Zaknoen, Henry S. Friedman Phase II Trial of Temozolomide in Patients With Progressive Low-Grade Glioma Journal of Clinical Oncology, Vol 21, Issue 4 (February 15), 2003: 646-651. (Clinical Study, Abstract+)
	Stege EM, Kros JM, de Bruin HG, Enting RH, van Heuvel I, Looijenga LH, van der Rijt CD, Smitt PA, van den Bent MJ Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine Cancer. 2005 Feb 15;103(4):802-9. (Clinical Study, Abstract)
	van den Bent MJ Can chemotherapy replace radiotherapy in low-grade gliomas? Time for randomized studies Semin Oncol. 2003 Dec;30(6 Suppl 19):39-44.(Review Article, Abstract)